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Abstract: Human T-lymphotropic virus-1 (HTLV-1) spreads efficiently between T-cells via 
a tight and highly organized cell-cell contact known as the virological synapse. It is now 
thought that many retroviruses and other viruses spread via a virological synapse, which 
may be defined as a virus-induced, specialized area of cell-to-cell contact that promotes the 
directed  transmission  of  the  virus  between  cells.  We  summarize  here  the  mechanisms 
leading to the formation of the HTLV-1 virological synapse and the role played by HTLV-1 
Tax protein. We propose a model of HTLV-1 transmission between T-cells based on the 
three-dimensional ultrastructure of the virological synapse. Finally, in the light of recent 
advances, we discuss the possible routes of HTLV-1 spread across the virological synapse. 
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1. Introduction  
Human  T-lymphotropic  virus  type  1  (HTLV-1)  is  a  complex  retrovirus,  classified  in  the 
Deltaretrovirus  genus  of  the  subfamily  Orthoretrovirinae.  The  majority  (about  95%)  of  infected 
individuals develop no associated disease (asymptomatic carriers; ACs). However, in a small fraction 
of  individuals,  infection  results  in  one  of  two  types  of  disease:  about  2–5%  develop  adult  T  cell 
leukemia/lymphoma  (ATLL)  [1],  and  a  further  0.5–3%  develop  one  or  more  of  a  range  of 
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inflammatory  diseases.  The  most  common  of  these  conditions  is  HTLV-1-associated 
myelopathy/tropical spastic paraparesis (HAM/TSP), an inflammatory disease of the central nervous 
system [2,3].  
Until recently, it was generally believed that HTLV-1 is latent
 in vivo [4-6]. However, there is
 
significant  evidence  to  the  contrary  [7,8].  The  presence
 of  high  frequencies  of  activated
 HTLV-1-
specific cytotoxic T lymphocytes (CTLs) [9,10] in the peripheral blood supports the hypothesis
 that the 
virus is not latent, i.e., there is ongoing viral
 transcription, and that this is greater in patients with 
HAM/TSP than
 in ACs. Direct evidence for selective proliferation of HTLV-1-infected T cells was 
obtained by Asquith et al. (2007) by in vivo labeling with deuterated glucose [11].  
In  this  review,  we  consider  the  mechanisms  of  cell-to-cell  spread  of  HTLV-1.  Following  the 
discovery  of  the  virological  synapse  (VS)  in  2003,  there  have  been  significant  advances  in  the 
understanding of the mechanism of formation of the synapse and in the locus of transfer of virions 
from cell to cell. We conclude that HTLV-1, as appears to be the case for HIV-1 and MLV, can be 
transferred from cell to cell both at sites of budding at the closely apposed plasma membranes at the 
VS and by lateral movement of preformed virions at, or near, the periphery of the cell-to-cell contact, 
where they may be protected in a ‘biofilm’ of extracellular matrix. 
2. HTLV-1 cell tropism, cell-to-cell spread and the VS  
HTLV-1 can infect a wide range of human cell types in vitro [12], but in vivo the virus is almost 
confined to the CD4
+ T lymphocyte subset [13-16]. Furthermore, most of the malignancies induced by 
HTLV-1 are tumors of CD4
+ T lymphocytes [17]. CD8
+ T lymphocytes can also carry the virus, but at 
a consistently lower frequency than CD4
+ T cells [18,19]. 
The  conjunction  of  two  observations  led  to  the  postulation  of  the  VS.  First,  direct  cell-to-cell 
contact is necessary for efficient transmission of HTLV-1 from an infected cell to a new host cell, both 
in vitro [20,21] and in vivo [22], where transmission depends on transfer of infected lymphocytes in 
breast milk [23-25], semen [26] or transfused blood products [27,28]. HTLV-1 virions are typically 
undetectable in the serum of infected individuals by RT-PCR. Virions are produced only by certain
 
continuous in vitro T cell lines: fresh, naturally infected
 lymphocytes do not produce cell-free HTLV-1 
particles. Furthermore,
 of the cell-free HTLV-1 virions that are produced by transfected
 T cells or 
continuous producer T cell lines, only one in 10
5 to 10
6 is infectious [29]. Second, HTLV-1-specific T 
cells are themselves infected
 more frequently with HTLV-1 than are T cells specific to other
 antigens. 
This preferential infection was evident in both CD8
+ T cells [18] and CD4
+ T cells [30]. These two 
observations raised
 the possibility that HTLV-1 transmission was assisted by the
 process of T cell 
antigen recognition. More precisely, HTLV-1
 might spread across the ‘immunological synapse’
 [31], 
the specialized area of contact that
 is formed between a lymphocyte and another cell in which distinct
 
protein  microdomains  mediate  adhesion,  antigen  recognition  and
  secretion  of  cytokines  or  lytic 
granules.
 Confocal microscopy of conjugates formed spontaneously
 between ex vivo CD4
+ cells from 
an HTLV-1-infected person and
 autologous (or allogeneic) lymphocytes revealed a structure
 at the 
cell–cell  junction,  which  indeed  resembled  the  immunological
  synapse  [32].  Polarization  of  the 
adhesion
 molecule talin and the microtubule organizing center (MTOC)
 to the cell–cell junction was 
accompanied  by  accumulation
 of  the  HTLV-1  core  protein  Gag  and  the  HTLV-1  genome  at  the
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cell-cell junction. After 2 h, both
 the Gag protein and the HTLV-1 genome were transferred from
 the 
infected to the uninfected cell [32]. 
A critical observation revealed the distinction between the immunological synapse and the structure 
formed between an HTLV-1-infected cell and another cell. In an immunological synapse, the MTOC 
in the responding T cell is polarized towards the antigen-presenting cell, such as a virus-infected cell. 
This polarization is triggered by engagement of the T-cell antigen receptor [33,34]. In contrast, in the 
cell-cell conjugates formed with an HTLV-1-infected cell, the MTOC was polarized inside the virus-
infected cell, not towards it. The results are shown in Table 1 [32].  
Table 1. HTLV-1-infected cells polarize their MTOCs to the cell-cell junction in CD4+ T-
cell conjugates. Two experiments were performed, each with fresh ex vivo CD4+ T cells 
from an unrelated HTLV-1-infected subject. Conjugates were allowed to form for 30 min 
(Subject 1) or 60 min (Subject 2), then were fixed and stained for HTLV-1 Gag p19 and 
tubulin alpha. Only conjugates containing two cells were counted. The figures denote the 
number (percentage) of cells whose MTOC was polarized to the cell-to-cell junction. Odds 
ratio
(a)  of  MTOC  polarization  in  Gag  p19+  cells,  comparing  the  number  of  polarized 
MTOCs with (polarized + not seen) MTOCs. This table was originally published in the 
material accompanying reference [32].  
MTOC 
orientation 
Uninfected 
control 
subject 
HTLV-1-infected subjects 
Subject 1  Subject 2 
Gag p19
–  Gag p19
+  Gag p19
–  Gag p19
+ 
Polarized %  79 (18.7)  85 (25.9)  163 (58.2)  45 (22.0)  59 (53.2) 
Not polarized %  322 (76.3)  217 (66.2)  111 (39.6)  160 (78.0)  52 (46.8) 
Not seen  21 (5)  26 (7.9)  6 (2.1)  0 (0.0)  0 (0.0) 
Total  422 (100.0)  328 (100.0)  280 (99.9)  205 (100.0)  111 (100.0) 
Odd ratio 
a  
(95% confidence 
interval) 
χ
2 =(P<<0.001) 
 
 
– 
3.98 (2.83 – 5.61) 
χ
2 = 63.9 (P<<0.001) 
4.02 (2.45–6.64) 
χ
2 = 30.4 (P<<0.001) 
Subject 1 and subject 2 combined: 
4.07 (3.07 – 5.39) 
χ
2 = 99.0 (P<<0.001) 
 
This observation showed that the mechanisms triggering the cytoskeletal polarization differed from 
the immunological synapse, and immediately suggested that the polarization was induced by HTLV-1 
itself, perhaps in order to transmit viral material to the uninfected cell.  
Inhibition of polarization and cell-to-cell transfer of HTLV-1 Gag protein at the cell-cell junction by 
the  microtubule  inhibitor  nocodazole  (30  µM)  confirmed  that  the  donor  cell’s  microtubule 
cytoskeleton plays a central part in cell-to-cell transmission of HTLV-1 [35,36]. Recently, Mazurov et 
al. [37] used an elegant new system of luciferase-expressing, replication-dependent vectors to quantify 
the infectivity of HTLV-1 and HIV-1 and the contribution of Tax protein to cell-to-cell transmission. Viruses 2010, 2                                       
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These authors found that cell-to-cell transmission of HTLV-1 was >10
4 times more efficient than cell-
free virus, whereas cell-to-cell transmission of HIV-1 was only two-fold more efficient. Disruption of 
the microtubules with nocodazole reduced HTLV-1 co-culture infectivity  by 85%, whereas HIV-1 
infectivity  was  reduced  by  60%.  In  addition,  the  authors  showed  that  the  induction  of  an 
immunological synapse between a Raji cell and a CD4
+ target cell did not increase infection with 
either  HIV-1  or  HTLV-1  virus-like  particles,  suggesting  that  cell-to-cell  infection  requires  the 
formation of a specialized VS [37]. These results confirm the exceptionally strong dependence of 
HTLV-1 transmission on cell-cell contact and the importance of cytoskeletal remodeling in the cell-to-
cell transmission of both HTLV-1 and HIV-1.  
Molecular  triggers  and  intracellular  pathways  that  cause  the  cytoskeleton  polarization  in  
HTLV-1-infected cells have now been identified (see below). Because both the mechanisms and the 
function of the HTLV-1-induced structure were distinct from the immunological synapse, the term 
‘virological synapse’ was used [32].  
3. Definition of the VS  
A VS may be defined as a virus-induced, specialized area of cell-cell contact that promotes the 
directed transmission of the virus between cells. Many viruses are known to spread efficiently by cell-
cell contact, but such spread typically takes place across normal, pre-existing cellular contacts.  In 
contrast, a VS is actively induced by contact between an infected cell and another cell. The viruses that 
benefit most strongly from transmission by a VS are therefore those that infect mobile cells, such as 
leukocytes. The VS maximizes the efficiency of transmission and limits the exposure of the virus to 
host defense mechanisms, both in time and space.  
4. Polarization of viral proteins at the VS  
The  distribution  of  the  HTLV-1  proteins  Gag,  Env  and  Tax  can  be  visualized  by  confocal 
microcopy (Figure 1), and electron microscopy (Figure 2) in naturally infected cells [32,35,36,38-41]. 
In a single isolated cell (not making contact with a target cell) Gag is detected in the cytoplasm, 
forming large cytoplasmic inclusions whose precise nature remains unknown [42]. These inclusions 
appear  to  be  randomly  distributed  around  the  periphery  of  the  cell  under  the  plasma  membrane. 
Virions  may  also  accumulate  on  the  outside  of  the  plasma  membrane  of  an  isolated  cell,  in  the 
extracellular  matrix  ([93]:  see  Section  9  below).  Env  protein  is  uniformly  distributed  around  the 
plasma membrane in an isolated cell; Tax protein is mostly nuclear but a significant fraction of Tax is 
present around the MTOC in association with the cis-Golgi compartment [35,43-45]. The distribution 
of Tax protein between the nucleus and the cytoplasm depends on the balance between ubiquitylation 
and sumoylation [44,46]. In cell conjugates formed between an HTLV-1 infected T-lymphocyte and 
autologous cells, the Gag and Env proteins are characteristically polarized toward the region of contact 
formed with the target cell [32,35,36,41]. In about 30% of cell-cell conjugates, a fraction of Tax also 
appears at the inner side of the plasma membrane in the region of cell-to-cell contact [35]: the function 
of  Tax  protein  in  this  location  is  unknown.  The  mechanisms  by  which  the  HTLV-1  proteins  are 
transported, sorted and delivered to the VS also remain unclear. Viruses 2010, 2                                       
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5. Polarization of the cytoskeleton to the VS 
The formation of the VS is accompanied by the polarization of the MTOC in the infected cell 
toward the cell contact formed with the target cell (Figure 1). This polarization is a good indication of 
the establishment of a VS [32,35,36,47]. The polarization depends on the integrity of both actin and 
microtubule components of the cytoskeleton and requires the activity of the small GTPases Rac1 and 
Cdc42 [35].  
As described above, the observation that the MTOC polarizes towards the cell-cell junction inside 
the HTLV-1-infected cell, rather than in a T cell responding to an antigen, revealed the distinction 
between the VS and the immunological synapse. The trigger that causes the microtubule polarization 
in the VS therefore cannot be delivered by the T-cell antigen receptor. It was thus postulated that two 
signals were required to trigger the MTOC polarization observed at the VS: one from cell-cell contact 
and one from the viral infection itself. Specifically, it was hypothesized that engagement of a receptor 
on the surface of the infected cell acted in synergy with a signal from an intracellular HTLV-1 protein 
to trigger the observed polarization. 
Figure 1. Polarization of HTLV-1 proteins and the microtubules network toward the VS 
formed  between  autologous  CD4+  cells  naturally  infected  with  HTLV-1.  
(A-C) HTLV-1 Gag protein. (D) HTLV-1 Tax protein. (A) Isolated cell. (C-D) autologous 
CD4+  conjugates.  Scale  bars  =  10µm.  Originally  published  in  Journal  of  Biological 
Chemistry [35]. 
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5.1. Cell surface trigger of MTOC polarization at the VS  
To identify the signal from cell-cell contact, latex beads coated with monoclonal antibodies were 
used to cross-link certain molecules on the surface of the infected T cell. As expected, cross-linking of 
the T cell receptor with an anti-CD3 monoclonal antibody caused efficient polarization of the MTOC 
towards the coated latex bead [47]. In fact, cross-linking of a number of other cell-surface molecules 
also triggers MTOC polarization [47], demonstrating the unusual mobility of the T cell’s microtubule 
cytoskeleton. However, engagement of either of two molecules, ICAM-1 (CD54) or the IL-2 receptor 
alpha  chain  (CD25),  caused  a  significantly  higher  frequency  of  MTOC  polarization  in  HTLV-1-
infected cells than in uninfected cells. The importance of ICAM-1 in triggering MTOC polarization 
was corroborated by two further observations. First, a soluble cyclic peptide derived from the region of 
LFA-1  that  normally  binds  to  ICAM-1  selectively  inhibited  the  observed  preferential  MTOC 
polarization  in  HTLV-1-infected  cells  towards  an  uninfected  cell.  Second,  the  selective  MTOC 
polarization  in  HTLV-1-infected  cells  was  abolished  when  the  target  cell  lacked  LFA-1,  but  was 
enhanced when the target cell expressed the constitutively actively form of LFA-1 [47]. The reason for 
selective polarization towards CD25 is less obvious: we have suggested that this results from  the 
known physical association between CD25 and ICAM-1 in the T cell plasma membrane [48].  
5.2. Intracellular trigger of MTOC polarization at the VS  
The  signal  from  ICAM-1  cross-linking  was  especially  effective  in  triggering  cytoskeletal 
polarization in cells infected with HTLV-1. What was the signal from HTLV-1 infection that acted in 
synergy with the ICAM-1 signal? The Tax protein of HTLV-1 was a strong candidate, because of its 
early  and abundant expression during HTLV-1  replication and its known capacity to transactivate 
genes  via  the  CREB,  NF-κB  and  SRF  pathways  [44,46,49-53].  By  transfecting  a  Tax  expression 
plasmid into Jurkat T cells, we showed [35] that Tax is indeed sufficient to explain the observed 
preferential cytoskeletal polarization in HTLV-1-infected cells. We then used a series of mutants of the 
Tax  protein  to  investigate  the  relationship  between  the  signaling  pathways  activated  by  Tax,  the 
intracellular localization of the Tax protein, and its ability to trigger MTOC polarization.  
Mazurov et al. [37] have recently quantified the contribution of Tax to the efficiency of HTLV-1 
transmission across the VS. Their results showed that Tax protein increased the efficiency of HTLV-1 
transmission by more than 10-fold, confirming the earlier observations [35]. Remarkably, Tax also 
increased the efficiency of cell-to-cell transmission of HIV-1 by more than 10-fold, and the authors 
concluded that HTLV-1 Tax protein is a major determinant of the difference between HTLV-1 and 
HIV-1 transmission. 
The cross-linking of ICAM-1 (reviewed in [54]) activates two distinct signaling pathways:
 one is 
RhoA-dependent [55],
 and the other involves Ras-MEK-ERK
 activation [56].
 We previously showed 
that MTOC polarization in
 HTLV-1-infected cells is independent of RhoA GTPase activation [35]. Our 
recent data, obtained both in naturally infected lymphocyte and transfected Jurkat T-cells, confirms 
that  MTOC  polarization  induced  by  the  cross-linking  of  ICAM-1  depends  on  the  Ras-MEK-ERK
 
pathway [36]. This pathway is distinct from that activated by
 TCR engagement [36]. Indeed, HTLV-1 Viruses 2010, 2                                       
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infection  significantly  reduced  the  frequency  of  MTOC
 polarization  caused  by  cross-linking  TCR 
(CD3) on the cell surface [47], which suggests a competition between the two pathways.
  
The identification of the major triggers involved in causing preferential microtubule polarization 
towards the VS provided a possible resolution of the long-standing paradox that HTLV-1 infection is 
almost confined to T cells in vivo, whereas it can infect almost any nucleated mammalian (and some 
avian)  cells  in  vitro.  First,  the  role  of  ICAM-1  can  explain  preferential  transmission  to  
LFA-1-positive  cells,  the  great  majority  of  which  are  T  cells.  Second,  the  role  of  microtubule 
polarization suggests that HTLV-1 has evolved specific mechanisms to subvert the unusual mobility of 
the T cell cytoskeleton in order to propagate. This in turn can explain the observation that, whereas 
HTLV-1 can infect other cell types in vitro such as epithelial cells and fibroblasts [29,57], it is not 
possible to propagate HTLV-1 in these cell types. That is, HTLV-1 can enter other cell types, but the 
infected cell is unable to pass the virus on to other cells. 
In view of the observed sensitivity of the T cell’s microtubule cytoskeleton to engagement of a 
range of cell-surface molecules, it is likely that several ligand-receptor interactions contribute to cell-
to-cell transmission of HTLV-1 [58,59]. However, the conclusion that ICAM-1 plays a particularly 
important role is reinforced by the observations that cross-linking of ICAM-1 can increase HTLV-1 
protein expression [60], and conversely, HTLV-1 infection upregulates expression of ICAM-1 on the 
infected cell surface [61-64].  
6. Transfer of viral protein and genome to target cells 
Confocal
 microscopy was used to examine the distribution of HTLV-1 Gag and Env proteins
 and 
the  HTLV-1  genome  in  fresh,  unstimulated  peripheral  blood
 mononuclear  cells  (PBMCs)  isolated 
directly from HTLV-1-infected
 individuals [32]. CD4
+ or CD8
+ T cells isolated from a HAM/TSP 
patient were allowed to form conjugates with T cells from a healthy uninfected
 donor for 120 min: in 
addition to accumulation of Gag p19 staining
 at the cell-cell junction, there was frequent Gag p19 
staining
 in the cells derived from the uninfected donor [32,35,41]. In addition to Gag protein, HTLV-1 
RNA  was  also  transferred
 from  infected  cell  to  uninfected  cell  [32].  The  HTLV-1  Gag  p19  was 
observed to transfer from CD4
+ T cells and CD8
+ T cells to both CD4
+ and CD8
+ allogeneic T cells. 
This  process  may  represent  the  initial  establishment
  of  HTLV-1  infection  in  a  newly  infected 
individual, which involves
 contact between allogeneic lymphocytes. Polarization of Gag complexes to 
the cell-cell junction and transfer to the uninfected cell were also observed in conjugates
 between CD4
+ 
T cells and both B cells and NK cells [32]. The kinetics of HTLV-1 Gag
 transfer showed a peak 
intensity between 90 and 210 minutes
 after initiation of conjugate formation [36]. This
 kinetics closely 
resembles  the  kinetics
  of  the  cell-to-cell  transfer  of  HIV-1-Gag  recently  reported  [65].  HTLV-1 
transfer is significantly reduced within this time frame either by depolymerization of the cytoskeleton 
(microtubules or microfilaments) or by inhibition of ERK phosphorylation and CREB activation in the 
infected donor T-cell [36]. Viruses 2010, 2                                       
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7. Role of microtubule cytoskeleton in the cell-to-cell transfer of Gag protein 
The microtubule organizing center (MTOC) is typically oriented to the area of cell-to-cell contact in 
lymphocyte
 conjugates where it lies immediately adjacent to the accumulation of HTLV-1
 Gag protein 
[32,35,36].  This  close  apposition  of  polarized  Gag  molecules
  to  the  MTOC  suggested  that  the 
microtubule cytoskeleton affected
 the polarization of Gag. In conjugates formed between infected and 
uninfected CD4
+ T cells, depolymerization of the microtubule network blocked the polarization and 
transfer of Gag protein [32,35,36]. There is a significant association
 between MTOC polarization and 
Gag  positivity  in  conjugates  between
  autologous  CD4
+  and  CD8
+  T  cells  from  an  infected  
individual [32].  
Recently,  the  HTLV-1  accessory  protein  p12  was
  reported  to  reduce  the  expression  of  
ICAM-1/2,  which  in  turn  prevents  the  destruction  of  HTLV-1–infected
 cells  by  NK  cells  [66].  In 
addition p12 has been shown to induce  LFA-1  clustering on the surface of infected T cells
 via a 
calcium-dependent signaling pathway, which is thought to promote HTLV-1 spread between T cells 
[67]. HTLV-1 Tax expression was also
 shown to strongly up-regulate ICAM-1 expression [61]. Thus, 
HTLV-1 appears to regulate the expression of adhesion molecules at the surface of infected T-cell 
using both Tax and p12 protein. However, the early expression of Tax protein and its powerful effect 
on ICAM-1 suggests that Tax will dominate – and so upregulate ICAM-1 – in the early stages of the 
infectious cycle, so promoting the formation of the VS.  
The association of Tax protein
 with the MTOC region in the infected T
 cell and its ability to activate 
CREB pathway are both required
 for the polarization observed during the formation
 of the HTLV-1 VS 
[36]. Tax also binds directly
 to the protein kinase MEKK1 [68], and this interaction might play a part 
in the synergistic induction
 of MTOC polarization by Tax and ICAM-1. However, Tax protein
 interacts 
with a large range of cellular proteins, including
 Ras p21 proactive 2 and cdc42/Rac effector kinase 
[69], which are
 a part of the Ras activation pathway. 
8. Ultrastructure of the VS: Electron tomography  
We investigated the three dimensional ultrastructure of the HTLV-1 VS using electron tomography 
(Figure  2)  of  immunostained  conjugates  formed  between  CD4
+  T  cells  from  HTLV-1-infected 
individuals and conjugates between MS9 cells (a chronically HTLV-1-infected cell line) and Jurkat 
cells [41].  
Enveloped HTLV-1 particles were identified in an intercellular space or "synaptic cleft” in the VS 
formed between a naturally infected lymphocyte and an autologous target lymphocyte (Figure 2). Each 
synaptic cleft is characteristically bounded by the tightly apposed membranes of the infected and target 
cells, with a membrane-membrane distance of ~20 nm (median 25.7 nm). This distance is consistent 
with measurements of intercellular separation between lymphocytes and target cells, and with data on 
the  conformation  of  ICAM-1/LFA-1  binding  from  electron  microscopy  and  X-ray  
crystallography [70-72]. However, the ultrastructural studies of the VS show that in the case of HIV-1 
the intercellular space is less tight than in the HTLV-1 VS and is therefore likely to be accessible to 
inhibitors both during and after virus assembly [73]. Viruses 2010, 2                                       
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Figure  2.  Three-dimensional  ultrastructure  of  the  VS.  Enveloped  HTLV-1  virions  are 
trapped  in  multiple  isolated  synaptic  clefts.  Cell-to-cell  transmission  of  HTLV-1  as 
observed in tomograms of the VS formed between HTLV-1 infected CD4+ T-cell (PBMC) 
and an autologous uninfected CD4+ T-cell as a target cell. These cells were stained against 
HTLV-1 Gag p19 matrix protein with a specific monoclonal antibody. (A, B) Projections 
along the z-axis of two subvolumes of the same tomogram showing viral transmission at 
two different locations. (C) Surface representation of the VS shown in (A, B): Several 
virions  (blue)  are  trapped  between  the  closely  apposed  plasma  membranes  (yellow).  
(D)  Tomogram  slice  showing  an  HTLV-1  particle  held  between  the  cell  membranes.  
(E) Surface representation of the virus transmission shown in D (cell membranes: yellow 
and orange, virus envelope: blue, virus core: magenta). (F, G) Tomogram slices through 
the two areas of virus transmission shown in (A) and (B), respectively, with a spacing of 
about  17  nm  (F)  and  25  nm  (G)  between  subsequent  slices.  Black  arrows  indicate  a 
protrusion linking the virus with the cell membrane. (H) Subsequent slices through the area 
of virus transmission shown in (D) with a spacing of about 17 nm. Black arrows indicate a 
protrusion linking the virus with the cell membrane. Scale bars: A, B 300 nm, D 500 nm, 
F, G 100 nm, H 200 nm. This figure was originally published in PLoS One [41].  
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The HTLV-1 VS typically contains more than one synaptic cleft, spatially distinct and separated by 
areas  of  close  membrane–membrane  apposition  (Figure  2,  A-C).  The  membrane  of  the  synaptic 
pockets presents sites of virus budding, and the pockets contain enveloped HTLV-1 particles [41]. This 
contrasts  with  the  immunological  synapse  where  secretory  lysosomes  are  secreted  into  a  single 
synaptic pocket in the cytotoxic synapse [74,75]. The size of HTLV-1 particles that originate from 
naturally infected CD4
+ T cells has a wide range (62 nm–173 nm), with a peak at about 100 nm similar 
to the variability in size of HIV-1 particles [76,77]. The directional nature of the process is indicated 
by  the  polarization  of  Gag  and  Tax  proteins,  and  the  MTOC  [32,35,47].  The  accumulation  of 
mitochondria near the VS (Figure 2, D) again resembles the immunological synapse [41,75].  
The ultrastructure of the HTLV-1 VS reconciles the requirement for cell contact and HTLV-1 Env 
protein for the spread of the virus, with the lack of detection of cell-free virions in the serum. Whereas 
most viruses spread by releasing large numbers of virions from the infected cell, HTLV-1 uses the 
mobility of the host cell to propagate from cell to cell. Sequestration in the synaptic cleft presumably 
allows efficient transfer of small numbers of virions, and may give the virions a degree of protection 
from components of the immune response (complement system and antibodies) (Figure 3, A1).  
9. Recent advances  
New routes have been recently described that may contribute to HTLV-1 spread in vivo. Jones and 
co-authors investigated the role of human dendritic cells (DCs) in the transmission of HTLV-1 [78]. 
DCs are potent antigen-presenting cells that play a central role in initiating the immune response. 
However, infection of DCs can impair their ability to mount an appropriate immune response. Indeed, 
many viruses infect DCs to facilitate their transmission including the retrovirus HIV-1 and the mouse 
mammary tumor virus [79-81]. Some viruses use the trafficking proprieties of DCs to facilitate their 
transport from the periphery to lymph nodes where they infect target cells.  
Jones et al. have shown that myeloid DCs (mDC) and plasmacytoid DCs (pDC) are efficiently and 
reproducibly infected in vitro with cell-free HTLV-1 virions released by chronically infected T cell 
lines (MT2, DB1) [78]. The infected DCs can rapidly transfer HTLV-1 to autologous primary CD4
+  
T-cells, resulting in a chronic productive infection of CD4
+ T cells ex vivo. The DC-T cell transmission 
of HTLV-1 is reduced by blocking Neuropilin-1 (NP-1) and heparin sulfate proteoglycans (HSPGs) 
[78], two molecules involved in the initial interaction of HTLV-1 with CD4
+ T-cells [82-85] and in the 
DC-T cell interaction [86,87]. DC-specific ICAM-3-grabbing nonintegrin (DC-SIGN) was also shown 
to facilitate the interaction of dendritic cells with HTLV-1-infected cells [88]. Recently it was reported 
that blocking any one of four molecules HSPGs, NRP-1, GLUT-1 or DC-SIGN led to reduction of 
virus binding to the cell; however, HTLV-1 transmission from DCs to T cells was mediated primarily 
by DC-SIGN [89]. Based on their findings and on the studies reporting the presence of viral proteins 
[90] and genome [91,92] in DCs isolated from HTLV-1-infected individuals, Jones et al. suggested 
that cell-free virus can also infect DCs in vivo (Figure 3, A2). It is possible that DCs play an important 
part in the early stages of HTLV-1 infection of a new host, by efficiently acquiring the virus and 
disseminating it to T cells. This system provides a new approach for dissection of the early events in 
HTLV-1-induced transformation and HTLV-1 infection.  Viruses 2010, 2                                       
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Figure  3.  Illustration  of  possible  routes  of  HTLV-1  spread  between  cells  in  vivo.  
(A) cell-to-cell transmission via intercellular synaptic cleft surrounded by a tight cell-cell 
contact between the donor and recipient cell, 1. Cell-free particles can be internalized by 
dendritic cells and are then transferred to lymphocyte only by cell-to-cell contact, 2. Virus 
particles  can  be  retained  on  the  cell  surface  in  a  biofilm-like-structure  before  lateral 
transfer to the recipient outside the cell-cell contact region, 3. (B) In an isolated HTLV-1-
infected lymphocyte, the viral proteins are not polarized. 
 
 
Pais-Correia et al. have reported evidence that HTLV-1 can also be transferred from cell to cell at 
the VS via biofilm-like extracellular viral assemblies [93]. By using electron and light microscopy 
analysis they detected extracellular viral clusters at the cell surface of  HTLV-1 infected cell after 
overnight incubation in vitro. These viral assemblies are carbohydrate-rich structures, suggesting the 
involvement of matrix-linker proteins in the adhesion and attachment of HTLV-1 to the surface of 
infected  cells.  The  authors  concluded  that  the  extracellular  matrix  component  and  cellular  lectins 
together  generate  a  cocoon-type  structure  that  concentrates  virions  in  a  confined  protective 
environment to escape the immune response. Consistent with the tomographic studies of HTLV-1-VS 
[41] the authors observed that infected T cells formed a tight contact with the target cell. However, 
their microscopic analysis suggested that many virions cluster overlapped the cell contact, bridging the 
gap  between  the  two  T  cell  surfaces  [93].  Extensive  washing  or  heparin  treatment  of  chronically 
infected cells and primary infected CD4
+ cells reduces their capacity to infect reporter target cells [93]. 
In contrast with an earlier report [78], the cell-free HTLV-1 particles recovered from the cell surface Viruses 2010, 2                                       
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clusters by extensive washing and heparin treatment were able to infect target T cells, although less 
efficiently than by cell-to-cell contact at the VS.  
Recent studies on Murine Leukemia Virus (MLV), a retrovirus related to HTLV-1, have quantified 
the sequential assembly and transmission events for individual viral particles in living cells [94,95]. 
The authors showed that MLV Gag protein is present in 10-fold greater amounts at the cell-cell contact 
area compared to the periphery and that the de novo assembly of virions is highly polarized toward the 
zone  of  cell-to-cell  contact  [94].  They  also  observed  that  a  fraction  of  30%  of  MLV  particles  is 
retained  at  the  infected  cell  surface  after  completion  of  assembly,  and  they  named  this  fraction 
“surfacing viruses”. These virions are competent for transmission to infected target cells after the 
establishment  of  a  physical  cell-to-cell  contact  [95].  This  fraction  may  represent  a  reservoir  of 
infectious virus particles that can be sequestered and later passed on to uninfected target cells upon the 
establishment of cell-to-cell contacts.  
We conclude that HTLV-1, like other retroviruses (notably HIV-1 and MLV), can be transferred 
between cells at more than one locus at the VS. The relative magnitude of cell-to-cell transmission of 
virions that bud within the cell contact zone and preformed virions at the periphery of the cell contact 
zone remains to be quantified (Figure 3, A3); this ratio may depend on the time interval between the 
onset of viral antigen expression and the formation of a cell-cell contact. 
To identify and quantify the mechanisms involved in the formation and function of the HTLV-1 
VS, experimental work in vitro has focused chiefly on two-cell conjugates. However, it is likely that, 
in vivo, an HTLV-1-expressing T-cell will make contact with more than one cell simultaneously in the 
low-velocity,  cell-rich  environment  of  the  lymphoid  circulation.  HIV-1  has  indeed  been  shown  to 
spread in culture from one infected cell to more than one recipient cell: the authors called the multiple 
contact a polysynapse [96]. These rosette-like structures, displaying Gag accumulation at each cell 
contact, were observed in infected lymphocytes and DCs. Microscopic analysis suggests that the cell 
contacts in the polysynapse can be formed simultaneously rather that one after another. Multifocal 
capping of assembled budding virions required for polysynapse formation is promoted by tetraspanins 
and plasma membrane mobility via lipid rafts. The actin and microtubules are also involved because 
nocodazole, cytochalasin D and latrunculin B inhibit the formation of polysynapses. The description of 
the virological polysynapse recalled the studies of multiple immunological synapse formation by T 
cells that interact simultaneously with cells presenting different antigenic stimuli [97]. These studies 
showed  that  the  MTOC  moves  repeatedly  between  the  different  cell-cell  contacts;  eventually  the 
secretory machinery becomes selectively polarized toward the antigen-presenting cell that provides the 
strongest  stimulus.  The  intensity  of  molecular  translocation  at  the  different  synapses  reflects  the 
strength of signals received via the T-cell receptor and accessory molecules [97]. 
The present studies carried out in vitro and ex vivo indicate that HTLV-1 may use more than one 
route  to  spread  between  CD4
+  T-cells.  However,  it  is  clear  that  efficient  propagation  of  HTLV-1 
depends on the close contact whose formation is triggered by the virus infection in the VS. While it is 
difficult  to  completely  exclude  the  possibility  of  cell-free  virion  transmission  of  HTLV-1  in  vivo,  
cell-free HTLV-1 particles are typically undetectable in serum even by RT-PCR, and transfusion of 
plasma or the cell-free blood product does not transfer HTLV-1 infection. It is possible that transfer of 
viral particles at the periphery of the VS involves the same molecular mechanisms that cause the Viruses 2010, 2                                       
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polarization of HTLV-1 protein and the cytoskeleton, as described above. However, this remains to be 
tested. 
10. Mechanism of HTLV-1 entry: Comparison of two possible mechanisms of HIV transmission  
The mechanism by which HTLV-1 penetrates the target cells is yet to be established. Endocytosis is 
an obligatory entry step for enveloped viruses whose fusion proteins are activated by acidic pH [98]. 
However, HIV can mediate fusion between adjacent target cells (“fusion from without”) and HIV Env 
expressed on effector cells promotes fusion with target cells at neutral pH [99]. 
10.1. Fusion from without at the cell membrane in intercellular pockets at the VS 
Certain  enveloped  viruses  such  as  herpes  simplex  virus  1  (HSV-1),  Sendai  virus,  and  many 
retroviruses, including HIV, have pH-independent fusion proteins and can therefore penetrate into cells 
by fusing directly with the plasma membrane. It is generally assumed that fusion events at the plasma 
membrane lead to productive infection, although this is difficult to prove because virus particles are 
also continuously endocytosed [98].  
Penetration of enveloped viruses occurs by membrane fusion catalyzed
 by fusion proteins in the 
viral envelope. The machinery involved
 is rather simple, at least when compared to the apparatus 
needed
 for intracellular membrane-fusion events. One reason for simplicity
 is that viral fusion factors 
are used only once. Fusion activity
 is triggered by cues in the form of receptor binding or low
 pH. They 
induce, as a rule, irreversible
 conformational changes. Membrane fusion is an elegant and effective 
way to deliver viral
 capsids into the cytosol. No macromolecular assemblies need
 to pass through a 
hydrophobic membrane  barrier. The underlying
 principle is the same as in intracellular membrane 
traffic;
 the viral envelope is a "transport vesicle", and the capsid
 is the cargo [100]. 
10.2. Endocytosis 
The  endocytic  entry  route  gives  many  advantages  to  the  virus:  (i)  the  endocytic  vesicles  are 
designed  to  traverse  the  barriers  imposed
  by  the  cortical  cytoskeleton  and  the  highly  structured 
cytoplasm, so endocytosis gives the virus efficient access into the cytoplasm; (ii) the incoming viruses
 
are exposed to compartmental environments that differ from the
 extracellular milieu, in particular the 
mildly acidic pH
 in endosomes provides an essential signal that triggers penetration
 and uncoating;  
(iii) if the penetration is lytic, endosomal membrane lysis is likely to be less damaging to the cell than 
lysis at the plasma membrane. However, it is possible that endocytosis leads to delivery of the virus to 
the lysosome,
 a degradative compartment and a dead-end for most viruses. This
 is why viruses have 
adapted to carefully adjust the threshold pH for
 activation to match that of early (pH 6 to 6.5) or late 
endosomes
 (pH 5 to 6) [100]. The early and late endosomes constitute
 distinct entry sites: this has been 
confirmed with dominant
 negative mutants of endosome-associated small guanosine triphosphatases
 
(GTPases) [101]. A constitutively inactive mutant of Rab5 (early
 endosome) blocked the entry of both 
Semliki Forest virus (pH 6.2) and influenza virus (pH 5.4), whereas the corresponding
 Rab7 mutant 
(late endosomes) only blocked influenza virus entry. The progress of individual virus particles through 
endocytic
  compartments  can  be  tracked  with  real-time  video  microscopy  [65,102].  Individual Viruses 2010, 2                                       
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fluorescent virus particles can be
 observed to bind to the cell surface, diffuse along the membrane,
 get 
trapped in coated pits or caveolae, enter by endocytosis, and move along microtubules. With the use of 
specific
 fluorescent dyes, the acidification of virus particles and the
 fusion of the viral envelope with 
cellular membranes can also be
 monitored. 
11. Summary and Conclusions  
1. A VS may be defined as a virus-induced, specialized area of cell-cell contact that promotes the 
directed transmission of the virus between cells. 
2. HTLV-1 relies almost exclusively on cell-to-cell transmission to spread, both within the host and 
between hosts. Only dendritic cells can be efficiently infected with cell-free HTLV-1: this route may 
be important during initial acquisition of infection. However, DCs can  infect T cells only by cell 
contact. 
3) The HTLV-1 VS has a large area of close (about 26 nm) apposition of the plasma membranes of 
the infected cell and the target cell; there is no evidence of fusion between the plasma membranes of 
the two cells. The viral proteins Gag, Env and Tax are polarized at the cell-cell junction.  
4)  The  integrity  and  function  of  both  actin  and  microtubule  cytoskeletons  are  required  for  the 
formation of the HTLV-1 VS and for transfer of HTLV-1 between cells. The MTOC is polarized to the 
cell-cell junction.  
5) HTLV-1 Tax protein acts in synergy with crosslinking of ICAM-1 on the infected cell surface, to 
cause polarization of the infected cell’s microtubule cytoskeleton to the VS. This polarization requires 
the  presence,  in  the  vicinity  of  the  MTOC,  of  a  Tax  molecule  competent  to  activate  the  CREB 
pathway. The ERK pathway is also required for MTOC polarization at the VS.  
6) An HTLV-1-infected cell can form more than one VS simultaneously (a “polysynapse”). The 
multiple contacts strongly resemble the multiple immunological synapses previously demonstrated. As 
in the multiple immunological synapses, it is likely that the dynamic microtubule cytoskeleton of the T 
cell moves between the respective cell contacts in a multiple VS.  
7) The closely apposed cell membranes at the VS are interrupted by multiple intercellular clefts or 
‘pockets’. Immunoelectron tomography has shown HTLV-1 Gag staining localized under the plasma 
membrane in these pockets. The pockets contain Gag-staining particles within the intercellular clefts 
consistent with the size and morphology of virions. Virions may be transferred to the target cell either 
across these clefts, or at the periphery of the cell contact, or (probably) both. 
8) Env protein is required for infectivity of HTLV-1. Both endocytosis and fusion from without 
(virion fusion with the plasma membrane) may contribute to infection of the target cell; the relative 
importance of the two routes remains unknown. 
9) The HTLV-1 VS appears to differ from the HIV-1 VS in the closeness of the cell-to-cell contact 
and the enhancing role of HTLV-1 Tax protein.  Viruses 2010, 2                                       
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